Multi-index quantitative detection card for atherosclerosis

Through the combined detection of multi-index quantitative detection cards, combined with endothelial cell adhesion factor, vascular cell adhesion factor and vascular endothelial growth factor, the problems of inconvenient detection of atherosclerosis and inaccurate evaluation of single markers in the prior art have been solved. Achieve rapid and accurate atherosclerosis diagnosis and cost-reducing effects.

CN222014227UActive Publication Date: 2024-11-15SUZHOU KUIKTAI BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202323348635.4
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2023-12-08
Publication Date
2024-11-15
Estimated Expiration
2033-12-08

AI Technical Summary

Technical Problem

The prior art is inconvenient to operate in atherosclerosis detection and takes a long time. A single biomarker cannot fully and accurately evaluate the disease, resulting in inaccurate diagnosis.

Method used

Provide a multi-index quantitative detection card, combining endothelial cell adhesion factor, vascular cell adhesion factor and vascular endothelial growth factor for joint detection, using specific detection antibodies labeled with time-resolved fluorescent microspheres or quantum dots, designed in detection instruments The unified inspection location in the system reduces manufacturing costs and inspection costs.

Benefits of technology

It has achieved a comprehensive and accurate assessment of atherosclerosis and related diseases, reduced detection costs, improved detection throughput, simple operation, accurate results, and able to detect three indicators simultaneously within 15 minutes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN222014227U_ABST
    Figure CN222014227U_ABST
Patent Text Reader

Abstract

The utility model discloses a multi-index quantitative detection card for atherosclerosis, which comprises a bottom plate, a sample pad, a combination pad, a detection pad and a sample absorption pad, and multiple indexes comprise endothelial cell adhesion factors, vascular cell adhesion factors and vascular endothelial growth factors. The combination pad comprises a specific detection antibody which is marked by time-resolved fluorescent microspheres or quantum dots and aims at the three indexes; three detection lines and a quality control line are distributed on the detection pad, the three detection lines are respectively coated with specific capture antibodies, and the quality control line is coated with haptens or antibodies capable of being combined with the specific detection antibodies. According to the detection card, three indexes can be jointly detected, atherosclerosis as well as pathogenesis, pathology and pathophysiological changes of coronary heart disease, cerebral infarction and peripheral vascular diseases which are possibly caused by atherosclerosis can be comprehensively and accurately evaluated, the manufacturing cost can be reduced, the detection flux can be improved, and the uniformity of detection positions of the detection card in a detection instrument can be ensured.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to the technical field of biotechnology diagnosis, in particular to a multi-index quantitative detection card for atherosclerosis. Background Art

[0002] Atherosclerosis (AS) is a chronic progressive pathological process caused by the action of multiple complex factors on different links. Its main feature is the accumulation of LDL-C in the damaged arterial wall to form plaques, resulting in reduced blood flow or blockage of blood outflow. It is the main cause of coronary heart disease, cerebral infarction and peripheral vascular disease.

[0003] At present, the detection of atherosclerosis is inconvenient and time-consuming, which is not conducive to the rapid diagnosis of atherosclerosis. Studies have found that the detection of three markers, intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and vascular endothelial growth factor (VEGF), is convenient for patient identification and diagnosis, risk stratification, prognosis assessment and treatment decision-making.

[0004] Intercellular adhesion molecule-1 (ICAM-1), also known as (CD-54), is a member of the immunoglobulin superfamily. During the initial formation of AS, after the vascular endothelium is damaged, the expression of ICAM-1 increases. Many experiments have confirmed that normal arterial endothelial cells and intimal smooth muscle cells express very little or no ICAM-1, while in atherosclerosis, a large amount of and persistent ICAM-1 expression appears on the endothelial cells, macrophages and smooth muscle cells of the blood vessels. The detection of ICAM-1 plays an important role in atherosclerosis.

[0005] Vascular cell adhesion molecule-1 (VCAM-1) belongs to the immunoglobulin superfamily, with a molecular weight of 100-110 kD. Its ligand is the VLA-4 molecule distributed on the surface of leukocytes. VCAM-1 is expressed on vascular endothelial cells, which can promote the adhesion of leukocytes and vascular endothelial cells, accelerate the migration of leukocytes under the vascular endothelium, and promote the proliferation of SMC. VCAM-1 plays an important role in atherosclerosis and accelerates the occurrence and development of atherosclerosis. Therefore, the detection of VCAM-1 is of great significance for atherosclerosis.

[0006] Vascular endothelial growth factor VEGF usually refers to VEGF-A. Its molecular structure consists of two identical subunits covalently linked by disulfide bonds to form a dimeric glycoprotein of antiparallel isomers with a molecular weight of 46kD. Studies have found that VEGF can upregulate the expression of MMP in inflammatory cells, degrade the extracellular matrix, cause the fibrous cap to become thinner, and eventually cause plaque rupture and bleeding, and then activate tissue factor (TF), which forms thrombi on the surface or stimulates vasospasm through the TF pathway, causing complete blockage of the coronary artery, leading to severe cardiovascular events such as acute myocardial infarction. Relevant detection of VEGF plays an important auxiliary role in diagnosing whether a patient has atherosclerosis.

[0007] In summary, a single biomarker can only reflect part of the disease information from one aspect, and cannot fully and accurately evaluate the etiology, pathology and pathophysiological changes of atherosclerosis and the coronary heart disease, cerebral infarction and peripheral vascular disease that may result. Therefore, it is necessary to provide a multi-index test card to improve the accuracy and specificity of atherosclerosis detection to solve the defects of existing tests. Utility Model Content

[0008] In order to solve the above technical problems, the purpose of the utility model is to provide a multi-index quantitative detection card for atherosclerosis, the detection indicators of which include endothelial cell adhesion factor, vascular cell adhesion factor and vascular endothelial growth factor. The three indicators are detected jointly to avoid the limitation that a single indicator cannot comprehensively and accurately evaluate the cause, pathology and pathophysiological changes of atherosclerosis and the coronary heart disease, cerebral infarction and peripheral vascular disease that may be caused. In addition, the detection card can reduce manufacturing costs, improve detection throughput, and ensure the uniformity of the detection position of the detection card in the detection instrument.

[0009] In order to achieve the above technical objectives and the above technical effects, the present invention is implemented through the following technical solutions:

[0010] A multi-index quantitative detection card for atherosclerosis, comprising a base plate and a sample pad, a binding pad, a detection pad and a sample suction pad stacked on the base plate, wherein the sample pad and the binding pad are arranged on one side of the detection pad, and the sample suction pad is arranged on the other side of the detection pad; the multi-index comprises three indicators, namely, endothelial cell adhesion factor, vascular cell adhesion factor and vascular endothelial growth factor, and the binding pad contains time-resolved fluorescent microspheres or quantum dots labeled specific detection antibodies for the three indicators; three detection lines and one quality control line are distributed on the detection pad, the three detection lines are respectively coated with specific capture antibodies used to capture the three indicators, and the quality control line is coated with haptens or antibodies that can bind to the specific detection antibodies.

[0011] Furthermore, the detection card also includes a shell, the sample pad, the binding pad, the detection pad, the sample suction pad and the bottom plate are installed in the shell, and the shell is provided with a sample addition hole and / or an inspection window.

[0012] Furthermore, the sample addition hole is arranged above the sample pad; and the inspection window is arranged above the three detection lines and one quality control line.

[0013] Furthermore, a limiting protrusion is provided on a portion of the shell close to the sample suction pad to limit the position of the detection card when it is inserted into the dry fluorescence detector.

[0014] Furthermore, the number of the conjugate pads is three, each of which contains specific detection antibodies for the three indicators marked with time-resolved fluorescent microspheres or quantum dots.

[0015] Furthermore, the three detection lines and one quality control line are parallel to each other and are arranged in sequence along the length direction of the detection pad.

[0016] Furthermore, the quality control line is close to the sample suction pad; and the three detection lines are located on the same side of the quality control line.

[0017] Furthermore, the sample pad and the binding pad are glass fiber pads or non-woven fabric pads, the detection pad is made of nitrocellulose membrane, the sample absorption pad is made of absorbent filter paper, and the bottom plate is a PVC board.

[0018] Furthermore, the detection card also includes a blood filter pad, and the sample pad, the binding pad, the blood filter pad, the detection pad, and the sample suction pad are overlapped on the bottom plate in sequence.

[0019] Furthermore, the quality control line is formed by coating goat anti-mouse IgG, goat anti-chicken IgY or goat anti-rabbit IgG antibodies.

[0020] Beneficial effects of the utility model:

[0021] The utility model realizes the combined detection of three indicators, namely, endothelial cell adhesion factor, vascular cell adhesion factor and vascular endothelial growth factor, and can comprehensively and accurately evaluate the causes, pathology and pathophysiological changes of atherosclerosis and the coronary heart disease, cerebral infarction and peripheral vascular disease that may be caused.

[0022] The utility model combines the detection of three indicators, which reduces the manufacturing cost of the detection card compared to the detection of a single indicator, and only occupies one detection slot of the detection instrument during detection, thereby reducing the detection cost and improving the throughput of simultaneous detection.

[0023] The utility model is provided with a limiting protrusion on the shell. When the test card is inserted into the test slot of the detection instrument (dry fluorescence detector), the limiting protrusion is stuck on the outside of the detection slot to limit the test card, so as to ensure the uniformity of the positions of the test lines and quality control lines of multiple test cards in the detection position in the detection instrument when multiple test cards are tested simultaneously, avoid batch differences caused by differences in measurement positions, and ensure the accuracy of detection.

[0024] The utility model can simultaneously perform quantitative detection on the above three indicators within 15 minutes, and has simple operation, high sensitivity, strong specificity and accurate results. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 This is a schematic diagram of the internal structure of a multi-index quantitative detection card for atherosclerosis according to Example 1 of the utility model.

[0026] Figure 2 This is a schematic diagram of the internal structure of a multi-index quantitative detection card for atherosclerosis according to Example 2 of the utility model.

[0027] Figure 3 The utility model is a schematic diagram of the external structure of the multi-index quantitative detection card for atherosclerosis.

[0028] Description of reference numerals:

[0029] 1: sample pad; 2: binding pad; 3: detection pad; 4: sample suction pad; 5: bottom plate; 6: outer shell, 61: sample addition hole, 62: inspection window, 63: limiting protrusion, 64: main body, 65: edge part, 66: push-pull part; 7: blood filter pad. DETAILED DESCRIPTION

[0030] The preferred embodiments of the present invention are described in detail below in conjunction with the accompanying drawings so that the advantages and features of the present invention can be more easily understood by those skilled in the art, thereby making a clearer and more definite definition of the protection scope of the present invention.

[0031] In the description of the present invention, it should be understood that the terms "front", "rear", "left", "right", "up", "down", etc., indicating directions or positional relationships are based on the directions or positional relationships shown in the accompanying drawings, and are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific direction, be constructed and operated in a specific direction, and therefore should not be understood as a limitation on the present invention.

[0032] like Figures 1 to 3A multi-index quantitative detection card for atherosclerosis is shown, the detection card comprises a base plate 5 and a sample pad 1, a conjugation pad 2, a detection pad 3 and a sample suction pad 4 stacked on the base plate 5, wherein the sample pad 1 and the conjugation pad 2 are arranged on one side of the detection pad 3, and the sample suction pad 4 is arranged on the other side of the detection pad 3. The multi-index comprises three indicators: endothelial cell adhesion factor (ICAM-1), vascular cell adhesion factor (VCAM-1) and vascular endothelial growth factor (VEGF); the number of the conjugation pads 2 is three, and the three conjugation pads are respectively provided with specific detection antibody coatings for the three indicators marked with time-resolved fluorescent microspheres or quantum dots on one side facing the detection pad (one conjugation pad corresponds to one indicator). Three detection lines (T1, T2, T3) and one quality control line (C) are distributed on the detection pad 3; the three detection lines and the quality control line are parallel to each other and arranged along the length direction of the detection pad 3; the quality control line is located on the left side of the sample suction pad 4, the quality control line is close to the sample suction pad 4, and the three detection lines are located on the same side of the quality control line. The spacing between two adjacent detection lines is equal to the spacing between the quality control line and the detection line close to the quality control line. The three detection lines are respectively coated with specific capture antibodies for the three indicators (one detection line corresponds to one indicator), and the quality control line is coated with a hapten or antibody that can bind to the specific detection antibody.

[0033] It should be noted that the specific capture antibody used for coating the test line can be a polyclonal antibody or a monoclonal antibody. The one used for coating the quality control line can be a hapten, or a goat anti-mouse IgG, goat anti-chicken IgY or goat anti-rabbit IgG antibody. The specific detection antibody can be a polyclonal antibody or a monoclonal antibody.

[0034] The specific detection antibody is coupled to the fluorescent microspheres; the fluorescent microspheres used for coupling are polystyrene microspheres, which are filled with chelates of lanthanide elements, selected from one of europium, terbium, samarium, neodymium or dysprosium; in the embodiment of the utility model, polystyrene microspheres filled with europium chelates are preferred. In addition, it should be noted that the time-resolved fluorescent microsphere labeling technology in the embodiment of the utility model is a prior art, which is known to those skilled in the art and will not be described in detail here.

[0035] The detection card also includes a housing 6, in which the sample pad 1, three binding pads 2, the detection pad 3, the sample suction pad 4 and the bottom plate 5 are installed, and the housing 6 is provided with a sample addition hole 61 and / or an inspection window 62. In the embodiment of the utility model, the sample addition hole 61 and the inspection window 62 are preferably provided at the same time. Specifically, Figure 3As shown, the sample addition hole 61 is arranged above the sample pad 1. By setting the sample addition hole 61, it is convenient to add samples directly through the sample addition hole without removing the outer shell 6 for adding samples. The inspection window 62 is arranged directly above the three test lines and one quality control line. By setting the inspection window 62, and the inspection window 62 is made of transparent material, it is convenient for the user to observe the color change of the test line in the outer shell 6 through the inspection window 62 to identify the test results. As an alternative embodiment, the sample addition hole may not be provided on the outer shell 6, but it may be designed as a detachable structure. When in use, the outer shell 6 is removed and the test operation is performed. Similarly, the outer shell 6 may not be provided with an inspection window. It should be noted that the material of the outer shell 6 is not particularly limited, and it can be selected from the conventional plastic material used for the test card in the prior art.

[0036] The inspection window 62 on the housing 6 is rectangular, and the orthographic projection area of ​​the inspection window 62 is greater than or equal to the area defined by the three test lines, one quality control line, and the spacing therebetween. The test lines and the quality control line are both located in the middle of the width direction of the inspection window 62, so that the user can fully view the three test lines and one quality control line through the inspection window 62. The sample loading hole 61 on the housing 6 can be designed as a rounded rectangular hole, and a 30° downwardly inclined surface with a width of two millimeters is built in, and the sample loading hole is set on the left side of the housing 6.

[0037] The shell 6 specifically includes a main body 64, an edge portion 65 and a push-pull portion 66. The sample addition hole 61 and the inspection window 62 are arranged on the main body 64 of the shell, and the push-pull portion 66 corresponds to the position of the sample suction pad 4; the two sides of the push-pull portion of the shell are respectively provided with limiting protrusions 63; the edge portion 65 of the shell 6 adopts a design style with different colors from the main body 64, the push-pull portion 66 and the limiting protrusion 63, for example, the main body 64 adopts white, the push-pull portion 66 adopts light yellow, the limiting protrusion 63 adopts light red, and the edge portion 65 adopts different colors such as blue or pink, so that the appearance of the detection card is more beautiful. In addition, the edge portion 65 is inclined from the inside to the outside and the corner position is transitioned by an arc. During processing, the shell 6 can be integrally injection molded.

[0038] Example 1

[0039] The structure of the test card of Example 1 is as follows Figure 1 and Figure 3As shown, it includes a shell 6, a bottom plate 5, and a sample pad 1 stacked on the bottom plate 5, three binding pads 2, a detection pad 3, and a sample suction pad 4; the shell 6 is provided with a sample addition hole 61 and an inspection window 62; three detection lines (T1, T2) and a quality control line (C) are distributed on the detection pad 3; the three detection lines are respectively coated with specific capture antibodies, which can respectively capture three indicators of endothelial cell adhesion factor (ICAM-1), vascular cell adhesion factor (VCAM-1) and vascular endothelial growth factor (VEGF); the quality control line is coated with a hapten that can bind to the specific detection antibody. The binding pad contains time-resolved fluorescent microspheres (containing europium chelates) labeled with specific detection antibodies for endothelial cell adhesion factor (ICAM-1), vascular cell adhesion factor (VCAM-1) and vascular endothelial growth factor (VEGF), which can specifically bind and detect the above three indicators. Other features of the detection card of this embodiment 1 can be designed according to the above.

[0040] The sample pad 1, the binding pad 2, the detection pad 3 and the sample suction pad 4 are bonded and fixed by using conventional adhesives in the prior art, so that the arrangement of each structural layer is more reliable.

[0041] The test card can be prepared and produced using existing well-known methods, and the preparation method of the test card will not be described in detail here.

[0042] The application method of the test card of this embodiment 1 is as follows:

[0043] (1) Take out the test card stored at room temperature from the sealed bag and place it flat on the test table;

[0044] (2) Pipette the sample to be tested that has been equilibrated to room temperature, add it to a centrifuge tube, then add the sample diluent to dilute it and mix it thoroughly;

[0045] (3) Add the mixed diluted sample to the sample well on the test card;

[0046] (4) After waiting for 15 minutes, insert the test card into the dry fluorescence detector (the end with the sample injection hole is inserted first, and pushed until the limit protrusion is stuck on the outside of the test slot). According to the pre-set standard curve, the endothelial cell adhesion factor (ICAM-1), vascular cell adhesion factor (VCAM-1) and vascular endothelial growth factor (VEGF) are quantitatively analyzed.

[0047] (5) If no fluorescent signal is detected on the quality control line C, the experiment fails and needs to be retested.

[0048] Example 2

[0049] The detection card of the second embodiment is different from the first embodiment in that the detection card further comprises a blood filter pad 7, a sample pad 1, three binding pads 2, a blood filter pad 7, a detection pad 3, and a sample suction pad 4 are sequentially overlapped on the bottom plate 5. Figure 2 As shown, the sample pad 1, the binding pad 2, and the blood filter pad 7 are located on the left side of the detection pad 3, and the sample suction pad 4 is located on the right side of the detection pad 3. The specific detection antibody is labeled with quantum dots, not time-resolved fluorescent microspheres. The remaining structure is the same as that of Example 1. The setting of the blood filter pad 7 can make the detection card better suitable for whole blood sample detection.

[0050] In the above embodiments 1 and 2, the blood filter pad 7, the sample pad 1, and the binding pad 2 are made of glass fiber or non-woven fabric, the detection pad 3 is made of nitrocellulose membrane, the sample absorption pad 4 is made of absorbent filter paper, and the base plate 5 is made of PVC.

[0051] The embodiment of the utility model does not describe or limit the thickness of the blood filter pad 7 , the sample pad 1 , the binding pad 2 , the detection pad 3 , the sample suction pad 4 and the bottom plate 5 .

[0052] The application method of the detection card of this embodiment 2 is the same as that of embodiment 1.

[0053] The detection principle of the detection card of the utility model is a prior art, which is known to those skilled in the art and will not be described or limited in detail herein. Qualitative judgment can be made by the depth of the color of the detection line, and the concentrations of endothelial cell adhesion factor, vascular cell adhesion factor and vascular endothelial growth factor are calculated and displayed according to the standard curve pre-set in the dry detector to achieve quantitative detection.

[0054] It is obvious to those skilled in the art that the present invention is not limited to the details of the exemplary embodiments described above, and that the present invention can be implemented in other specific forms without departing from the spirit or essential features of the present invention. Therefore, the embodiments should be regarded as exemplary and non-restrictive from any point of view, and the scope of the present invention is defined by the appended claims rather than the above description, and it is intended that all changes falling within the meaning and scope of the equivalent elements of the claims be included in the present invention. Any reference numeral in a claim should not be regarded as limiting the claim to which it relates.

[0055] In addition, it should be understood that although the present specification is described according to implementation modes, not every implementation mode contains only one independent technical solution. This description of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation modes that can be understood by those skilled in the art.

Claims

1. A multi-index quantitative detection card for atherosclerosis, the detection card comprising a base plate and a sample pad, a binding pad, a detection pad and a sample suction pad stacked on the base plate, wherein: The sample pad and the binding pad are arranged on one side of the detection pad, and the sample suction pad is arranged on the other side of the detection pad, characterized in that the multiple indicators include three indicators: endothelial cell adhesion factor, vascular cell adhesion factor and vascular endothelial growth factor, and the binding pad contains time-resolved fluorescent microspheres or quantum dots labeled with specific detection antibodies for the three indicators; three detection lines and one quality control line are distributed on the detection pad, and the three detection lines are respectively coated with specific capture antibodies used to capture the three indicators, and the quality control line is coated with haptens or antibodies that can bind to the specific detection antibodies; The detection card also includes a shell, the sample pad, the binding pad, the detection pad, the sample suction pad and the bottom plate are installed in the shell, and the shell is provided with a sample addition hole and / or an inspection window; A limiting protrusion is provided on the portion of the shell close to the sample suction pad to limit the position when the detection card is inserted into the dry fluorescence detector.

2. A multi-index quantitative detection card for atherosclerosis according to claim 1, characterized in that: The sample addition hole is arranged above the sample pad; and the inspection window is arranged above the three detection lines and one quality control line.

3. A multi-index quantitative detection card for atherosclerosis according to claim 1, characterized in that: The number of the conjugate pads is three, each of which contains specific detection antibodies for the three indicators marked with time-resolved fluorescent microspheres or quantum dots.

4. A multi-index quantitative detection card for atherosclerosis according to claim 1, characterized in that: The three detection lines and one quality control line are parallel to each other and are arranged in sequence along the length direction of the detection pad.

5. A multi-index quantitative detection card for atherosclerosis according to claim 4, characterized in that: The quality control line is close to the sample suction pad; and the three detection lines are located on the same side of the quality control line.

6. A multi-index quantitative detection card for atherosclerosis according to claim 1, characterized in that: The sample pad and the binding pad are glass fiber pads or non-woven fabric pads, the detection pad is made of nitrocellulose membrane, the sample suction pad is made of absorbent filter paper, and the bottom plate is a PVC board.

7. A multi-index quantitative detection card for atherosclerosis according to claim 1, characterized in that: The detection card also includes a blood filter pad, and the sample pad, the binding pad, the blood filter pad, the detection pad, and the sample suction pad are overlapped on the bottom plate in sequence.

8. A multi-index quantitative detection card for atherosclerosis according to claim 1, characterized in that: The quality control line is formed by coating goat anti-mouse IgG, goat anti-chicken IgY or goat anti-rabbit IgG antibody.